Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil
· Delayed Price · Currency is BRL 10.26
-0.17 (-1.63%)
At close: Mar 9, 2026
Blau Farmacêutica Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,370 | 2,337 | 2,916 | 4,681 | 6,530 | - | Upgrade
|
| Market Cap Growth | 10.23% | -19.87% | -37.70% | -28.32% | - | - | Upgrade
|
| Enterprise Value | 2,589 | 2,442 | 3,041 | 4,231 | 6,028 | - | Upgrade
|
| Last Close Price | 10.26 | 9.35 | 11.29 | 17.76 | 23.83 | - | Upgrade
|
| PE Ratio | 7.32 | 10.76 | 11.67 | 12.88 | 20.08 | - | Upgrade
|
| Forward PE | 7.99 | 8.13 | 12.65 | 11.36 | 15.20 | - | Upgrade
|
| PS Ratio | 1.34 | 1.33 | 2.12 | 3.33 | 4.78 | - | Upgrade
|
| PB Ratio | 1.02 | 1.09 | 1.46 | 2.58 | 3.99 | - | Upgrade
|
| P/TBV Ratio | 1.11 | 1.19 | 1.60 | 2.82 | 4.39 | - | Upgrade
|
| P/FCF Ratio | 14.29 | 6.41 | 40.99 | 160.06 | 1100.43 | - | Upgrade
|
| P/OCF Ratio | 6.09 | 4.61 | 13.22 | 27.23 | 42.37 | - | Upgrade
|
| PEG Ratio | 0.47 | 0.45 | 4.22 | 0.58 | 0.75 | - | Upgrade
|
| EV/Sales Ratio | 1.46 | 1.39 | 2.22 | 3.01 | 4.41 | - | Upgrade
|
| EV/EBITDA Ratio | 5.56 | 6.44 | 6.36 | 9.01 | 12.70 | - | Upgrade
|
| EV/EBIT Ratio | 6.19 | 7.21 | 6.78 | 9.36 | 13.20 | - | Upgrade
|
| EV/FCF Ratio | 15.61 | 6.70 | 42.74 | 144.69 | 1015.90 | - | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.26 | 0.31 | 0.17 | 0.23 | 3.12 | Upgrade
|
| Debt / EBITDA Ratio | 1.17 | 1.45 | 1.26 | 0.66 | 0.79 | 1.70 | Upgrade
|
| Debt / FCF Ratio | 3.29 | 1.53 | 8.55 | 10.66 | 63.11 | 4.80 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.03 | 0.10 | -0.18 | -0.33 | 2.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.51 | 0.17 | 0.42 | -0.71 | -1.15 | 1.18 | Upgrade
|
| Net Debt / FCF Ratio | 1.41 | 0.18 | 2.83 | -11.35 | -92.40 | 3.31 | Upgrade
|
| Asset Turnover | 0.52 | 0.54 | 0.49 | 0.58 | 0.76 | 1.18 | Upgrade
|
| Inventory Turnover | 1.68 | 1.78 | 1.47 | 1.50 | 1.88 | 2.43 | Upgrade
|
| Quick Ratio | 1.37 | 1.99 | 2.75 | 2.99 | 3.70 | 1.30 | Upgrade
|
| Current Ratio | 2.90 | 3.12 | 4.63 | 4.52 | 4.95 | 2.20 | Upgrade
|
| Return on Equity (ROE) | 14.32% | 10.30% | 12.98% | 20.88% | 34.89% | 104.43% | Upgrade
|
| Return on Assets (ROA) | 7.62% | 6.55% | 10.09% | 11.71% | 15.85% | 24.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.08% | 11.23% | 18.03% | 27.05% | 34.35% | 51.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.20% | 11.80% | 16.50% | 21.30% | 23.00% | 42.80% | Upgrade
|
| Earnings Yield | 13.70% | 9.30% | 8.57% | 7.76% | 4.98% | - | Upgrade
|
| FCF Yield | 7.00% | 15.60% | 2.44% | 0.63% | 0.09% | - | Upgrade
|
| Dividend Yield | 3.40% | - | 2.61% | 2.79% | - | - | Upgrade
|
| Payout Ratio | 19.81% | 25.83% | 26.48% | 37.30% | 32.02% | 129.32% | Upgrade
|
| Buyback Yield / Dilution | -0.52% | - | 0.08% | 0.87% | -13.84% | -4.39% | Upgrade
|
| Total Shareholder Return | 2.88% | - | 2.70% | 3.66% | -13.84% | -4.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.